Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122531) titled 'Recovery With Exogenous Ketones and Antipsychotics' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Universite de Sherbrooke
Condition:
First Episode Psychosis
Intervention:
Other: Medium chain triglyceride oil
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 25, 2025
Target Sample Size: 15
Countries of Recruitment:
Canada
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07122531
Published by HT Digital Content Services with...